Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-653-7 | CAS number: 55466-76-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In a guideline study, to GLP, the acute oral LD50 of ruthenium acetate was determined to be greater than 2000 mg/kg bw (Allen, 1995a).
In a guideline study, to GLP, the acute dermal LD50 of ruthenium acetate was determined to exceed 2000 mg/kg bw , as no deaths occurred at this limit dose (Sanders, 2004).
No relevant acute inhalation toxicity data were identified.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06-Nov-1995 to 06-Dec-1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (OECD 401)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- (deleted 17-Dec-2002)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Version / remarks:
- (now obsolete)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Margate, Kent
- Age at study initiation: 5-8 weeks
- Weight at study initiation: Males 150-167 g, females 138-160 g
- Fasting period before study: Yes, overnight
- Housing: Solid-floor polypropylene cages with wood flakes
- Diet (e.g. ad libitum): Rat and mouse expanded diet no. 1, ad libitum
- Water (e.g. ad libitum): Mains drinking water, ad libitum
- Acclimation period: >=5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-22
- Humidity (%): 46-59
- Air changes (per hr): ~15
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: 06-Nov-1995 To: 06-Dec-1995 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/ml
- Amount of vehicle (if gavage): 10 ml/kg bw
- Justification for choice of vehicle: none stated, but well-known vehicle
- Purity: not stated, but distilled water
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg bw
- Doses:
- Single dose: 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
- Observation for deaths or overt signs of toxicity: 0.5, 1, 2 and 4 hours after dosing, then once daily for 14 days
- Body weights: days 0, 7 and 14 of the study
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs (overt signs of toxicity and behavioural and clinical observations) and body weight - Statistics:
- An estimate of the acute oral medial lethal dose (LD50) was made using mortality data from the study
- Preliminary study:
- 1 male and 1 female were dosed at 2000 mg/kg bw and observed for 5 days. As no toxicity was observed, a dose of 2000 mg/kg bw was selected for the main study.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No deaths
- Clinical signs:
- other: No signs of systemic toxicity
- Gross pathology:
- No abnormalities
- Other findings:
- - Organ weights: not done
- Histopathology: not done
- Potential target organs: not done
- Other observations: not done - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In a guideline study, to GLP, the acute oral LD50 of ruthenium acetate in rats was >2000 mg/kg bw .
- Executive summary:
Ruthenium acetate was tested for its acute oral toxicity in rats, according to OECD Test Guideline 401. Following a range-finding study in which no toxicity was observed at 2000 mg/kg bw, the main study was performed at this dose level (limit test). Sprague-Dawley rats (5/sex) were administered the test substance by gavage in water at 2000 mg/kg bw and subsequently observed for 14 days.
There were no deaths, no overt signs of toxicity, no effect on body weight and no abnormalities were seen at necropsy. The acute oral LD50 of ruthenium acetate in rats was >2000 mg/kg bw under the conditions of the test.
Based on the results of this study, the test item should not be classified for acute oral toxicity according to EU CLP criteria (EC 1272/2008).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Overall, good-quality database which meets REACH Standard Information Requirements.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21-Jul-04 to 04-Aug-04
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Margate, Kent
- Age at study initiation: 8-12 weeks
- Weight at study initiation: >=200 g, "the weight variation did not exceed +- 20% of the mean weight for each sex"
- Fasting period before study: no data
- Housing: 5/cage; solid floor polypropylene cages with woodflakes, "the animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study"
- Diet (e.g. ad libitum): Certified Rat and Mouse Diet (Code 5LF2), ad libitum
- Water (e.g. ad libitum): mains water, ad libitum
- Acclimation period: >=5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 20-70
- Air changes (per hr): >=15
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: 14-Jul-04 To: 22-Jul-04 - Type of coverage:
- semiocclusive
- Vehicle:
- arachis oil
- Details on dermal exposure:
- TEST SITE
- Area of exposure: not specified in cm2, but as 10% of total body surface area
- % coverage: 10
- Type of wrap if used: surgical gauze covered with self-adhesive bandage
REMOVAL OF TEST SUBSTANCE
- Washing (if done): wiped with cotton wool moistened with arachis oil
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg bw
- Concentration (if solution): moistened with vehicle
- Constant volume or concentration used: yes
- For solids, paste formed: no data, but described as being moistened with vehicle, rather than dissolved in it
VEHICLE
- Amount(s) applied (volume or weight with unit): sufficient to moisten the required weight of test material
- Concentration (if solution): no data, but used to moisten test material, rather than to dissolve it
- Lot/batch no. (if required): no data
- Purity: no data, but described as "arachis oil BP" - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5/sex
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
- observervations - 0.5, 1, 2 and 4 hours after dosing, then once daily for 14 days
- body weight - days 0, 7 and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, dermal reactions - Statistics:
- not done
- Preliminary study:
- not applicable
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- no deaths
- Clinical signs:
- other: no signs of systemic toxicity
- Gross pathology:
- no abnormalities
- Other findings:
- - Organ weights: not examined
- Histopathology: not examined
- Potential target organs: not examined
- Other observations:
- dermal reactions - grey-coloured staining at all treatment sites on day 1 - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In a guideline study, conducted to GLP, the acute dermal LD50 of ruthenium acetate in rats was found to exceed 2000 mg/kg bw .
- Executive summary:
In an acute dermal toxicity test, conducted according to OECD Test Guideline 402 and to GLP, groups of 5 male and 5 female rats were dermally exposed to ruthenium acetate (moistened with arachis oil) for 24 hr (application to the shaved skin under semi-occlusion). Animals were observed at 0.5, 1, 2 and 4 hr after the start of exposure and then once daily over a 2-week period. There was no control group.
There were no deaths, clinical signs, gross pathological effects or indications of skin irritation in any of the animals. The acute dermal LD50 of ruthenium acetate is greater than 2000 mg/kg bw in rats.
Based on the results of this study, ruthenium acetate should not be classified for acute dermal toxicity according to EU CLP criteria (EU 1272/2008).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Overall, good-quality database which meets REACH Standard Information Requirements.
Additional information
No relevant human acute toxicity data were identified.
Ruthenium acetate was tested for its acute oral toxicity in rats, according to OECD Test Guideline 401. Following a range-finding study in which no toxicity was observed at 2000 mg/kg bw, the main study was performed at this dose level (limit test). Sprague-Dawley rats (5/sex) were administered the test substance by gavage in water at 2000 mg/kg bw and subsequently observed for 14 days. There were no deaths, no overt signs of toxicity, no effect on body weight and no abnormalities were seen at necropsy. The acute oral LD50 of ruthenium acetate in rats was >2000 mg/kg bw under the conditions of the test (Allen, 1995a).
In an acute dermal toxicity test, conducted according to OECD Test Guideline 402 and to GLP, groups of 5 male and 5 female rats were dermally exposed to ruthenium acetate (moistened with arachis oil) for 24 hr (application to the shaved skin under semi-occlusion). Animals were observed at 0.5, 1, 2 and 4 hr after the start of exposure and then once daily over a 2-week period. There was no control group. There were no deaths, clinical signs, gross pathological effects or indications of skin irritation in any of the animals. The acute dermal LD50 of ruthenium acetate is greater than 2000 mg/kg bw in rats (Sanders, 2004).
No acute inhalation toxicity data were identified, or are required.
Justification for classification or non-classification
Based on the results of the available reliable acute oral and dermal rat studies, hexakis[mu-(acetato-O:O')]-μ3-oxo-triangulo-triruthenium acetate / ruthenium acetate does not require classification for acute toxicity by the oral and dermal routes, according to EU CLP criteria (EC 1272/2008).
No clear evidence of specific target organ toxicity was noted. As such, classification for STOT-SE is not considered appropriate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.